-
2
-
-
0023789547
-
Khellin, a natural occurring furochromone, used for the photochemotherapy of skin diseases: Mechanism of action
-
Vedaldi D., Caffieri S., Dall'Acqua F., Andreassi L., Bovalini L., Martelli P. Khellin, a natural occurring furochromone, used for the photochemotherapy of skin diseases: mechanism of action. Il Farmaco, Ed. Sci. 43:(4):1988;333-346.
-
(1988)
Il Farmaco, Ed. Sci.
, vol.43
, Issue.4
, pp. 333-346
-
-
Vedaldi, D.1
Caffieri, S.2
Dall'Acqua, F.3
Andreassi, L.4
Bovalini, L.5
Martelli, P.6
-
3
-
-
0023934506
-
Treatment of vitiligo with khellin and ultraviolet A
-
Ortel B., Tanew A., Honigsmann H. Treatment of vitiligo with khellin and ultraviolet A. J. Am. Acad. Dermatol. 18:(4):1988;693-701.
-
(1988)
J. Am. Acad. Dermatol.
, vol.18
, Issue.4
, pp. 693-701
-
-
Ortel, B.1
Tanew, A.2
Honigsmann, H.3
-
4
-
-
0026598313
-
Guidelines for the treatment of vitiligo
-
Antoniou C., Katsambas A. Guidelines for the treatment of vitiligo. Drugs. 43:(4):1992;490-498.
-
(1992)
Drugs
, vol.43
, Issue.4
, pp. 490-498
-
-
Antoniou, C.1
Katsambas, A.2
-
5
-
-
0020554775
-
Preliminary report on the therapeutic effect of khellin in psoriasis
-
Abdel-Fattah A., Aboul-Enein M.N., Wassel G., El-Menshawi B. Preliminary report on the therapeutic effect of khellin in psoriasis. Dermatologica. 167:(2):1983;109-110.
-
(1983)
Dermatologica
, vol.167
, Issue.2
, pp. 109-110
-
-
Abdel-Fattah, A.1
Aboul-Enein, M.N.2
Wassel, G.3
El-Menshawi, B.4
-
8
-
-
0026528034
-
Photochemotherapy with topical khellin and sunlight in vitiligo
-
Orecchia G., Perfetti L. Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology. 184:(2):1992;120-123.
-
(1992)
Dermatology
, vol.184
, Issue.2
, pp. 120-123
-
-
Orecchia, G.1
Perfetti, L.2
-
9
-
-
0031927076
-
Topical photochemotherapy of vitiligo with a new khellin formulation: Preliminary clinical results
-
Orecchia G., Sangalli M.E., Gazzaniga A., Giordano F. Topical photochemotherapy of vitiligo with a new khellin formulation: preliminary clinical results. J. Dermatol. Treat. 9:1998;65-69.
-
(1998)
J. Dermatol. Treat.
, vol.9
, pp. 65-69
-
-
Orecchia, G.1
Sangalli, M.E.2
Gazzaniga, A.3
Giordano, F.4
-
11
-
-
0001593336
-
Iontophoretic drug delivery
-
K.A. Walters, & J. Hadgraft. New York: Marcel Dekker
-
Green P.G., Flanagan M., Shroot B., Guy R.H. Iontophoretic drug delivery. Walters K.A., Hadgraft J. Pharmaceutical Skin Penetration Enhancement. 1993;311-333 Marcel Dekker, New York.
-
(1993)
Pharmaceutical Skin Penetration Enhancement
, pp. 311-333
-
-
Green, P.G.1
Flanagan, M.2
Shroot, B.3
Guy, R.H.4
-
12
-
-
0029099183
-
Modern iontophoresis for local drug delivery
-
Gangarosa L.P., Hill J.M. Modern iontophoresis for local drug delivery. Int. J. Pharm. 123:1995;159-171.
-
(1995)
Int. J. Pharm.
, vol.123
, pp. 159-171
-
-
Gangarosa, L.P.1
Hill, J.M.2
-
13
-
-
0032472350
-
In vitro acyclovir distribution in human skin layers after transdermal iontophoresis
-
Volpato N.M., Nicoli S., Laureri C., Colombo P., Santi P. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J. Control. Rel. 50:1998;291-296.
-
(1998)
J. Control. Rel.
, vol.50
, pp. 291-296
-
-
Volpato, N.M.1
Nicoli, S.2
Laureri, C.3
Colombo, P.4
Santi, P.5
-
14
-
-
0026928482
-
The role of electroosmotic flow in transdermal iontophoresis
-
Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Del. Rev. 9:1992;201-237.
-
(1992)
Adv. Drug Del. Rev.
, vol.9
, pp. 201-237
-
-
Pikal, M.J.1
-
15
-
-
0026734912
-
In vitro and in vivo iontophoresis of a tripeptide across nude rat skin
-
Green P.G., Shroot B., Bernerd B., Pilgrim W.R., Guy R.H. In vitro and in vivo iontophoresis of a tripeptide across nude rat skin. J. Control. Release. 20:1992;209-218.
-
(1992)
J. Control. Release
, vol.20
, pp. 209-218
-
-
Green, P.G.1
Shroot, B.2
Bernerd, B.3
Pilgrim, W.R.4
Guy, R.H.5
-
16
-
-
0027936732
-
Preformulation studies and formulation strategies on khellin, an old/new antivitiligo agent: Interaction with cyclodextrins, solubility in mixed solvent systems and permeation through artificial membranes
-
Giordano F., Rillosi M., Benelli P., Sangalli M.E., Bettinetti G., Orecchia G., Gazzaniga A. Preformulation studies and formulation strategies on khellin, an old/new antivitiligo agent: interaction with cyclodextrins, solubility in mixed solvent systems and permeation through artificial membranes. Eur. J. Pharm. Biopharm. 40:(4):1994;232-236.
-
(1994)
Eur. J. Pharm. Biopharm.
, vol.40
, Issue.4
, pp. 232-236
-
-
Giordano, F.1
Rillosi, M.2
Benelli, P.3
Sangalli, M.E.4
Bettinetti, G.5
Orecchia, G.6
Gazzaniga, A.7
-
17
-
-
0019136505
-
Khellin determination in human serum and urine by high-performance liquid chromatography
-
El-Yazigi A., Said S.A. Khellin determination in human serum and urine by high-performance liquid chromatography. J. Pharm. Sci. 69:(12):1980;1434-1436.
-
(1980)
J. Pharm. Sci.
, vol.69
, Issue.12
, pp. 1434-1436
-
-
El-Yazigi, A.1
Said, S.A.2
-
19
-
-
0031002893
-
Binding of prednisolone and its ester prodrugs in the skin
-
Hikima T., Tojo K. Binding of prednisolone and its ester prodrugs in the skin. Pharm. Res. 14:(2):1997;197-202.
-
(1997)
Pharm. Res.
, vol.14
, Issue.2
, pp. 197-202
-
-
Hikima, T.1
Tojo, K.2
-
20
-
-
0026506486
-
Acyclovir bioavailability in human skin
-
Parry G.E., Dunn P., Shah V.P., Pershing L.K. Acyclovir bioavailability in human skin. J. Invest. Dermatol. 98:(6):1992;856-863.
-
(1992)
J. Invest. Dermatol.
, vol.98
, Issue.6
, pp. 856-863
-
-
Parry, G.E.1
Dunn, P.2
Shah, V.P.3
Pershing, L.K.4
-
21
-
-
0023548025
-
Pharmacokinetics of khellin in rabbits: Oral, intravenous, and intramuscular administration
-
El-Yazigi A., Saleh I. Pharmacokinetics of khellin in rabbits: oral, intravenous, and intramuscular administration. Drug. Dev. Ind. Pharm. 13:(14):1987;2529-2540.
-
(1987)
Drug. Dev. Ind. Pharm.
, vol.13
, Issue.14
, pp. 2529-2540
-
-
El-Yazigi, A.1
Saleh, I.2
-
22
-
-
0027291215
-
Convective solvent flow across the skin during iontophoresis
-
Kim A., Green P.G., Rao G., Guy R.H. Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10:1993;1315-1320.
-
(1993)
Pharm. Res.
, vol.10
, pp. 1315-1320
-
-
Kim, A.1
Green, P.G.2
Rao, G.3
Guy, R.H.4
-
23
-
-
0023854208
-
Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis
-
Burnette R.R., Ongpipattanakul B. Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J. Pharm. Sci. 77:1988;132-137.
-
(1988)
J. Pharm. Sci.
, vol.77
, pp. 132-137
-
-
Burnette, R.R.1
Ongpipattanakul, B.2
-
24
-
-
0029955055
-
Transdermal permeation of alniditan by iontophoresis: In vitro optimization and human pharmacokinetic data
-
Jadoul A., Mesens J., Caers W., deBeukelaar F., Crabbe R., Preat V. Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic data. Pharm. Res. 13:(9):1996;1348-1353.
-
(1996)
Pharm. Res.
, vol.13
, Issue.9
, pp. 1348-1353
-
-
Jadoul, A.1
Mesens, J.2
Caers, W.3
DeBeukelaar, F.4
Crabbe, R.5
Preat, V.6
-
25
-
-
0029919084
-
Reverse iontophoresis - Parameters determining electroosmotic flow: I. pH and ionic strength
-
Santi P., Guy R.H. Reverse iontophoresis - Parameters determining electroosmotic flow: I. pH and ionic strength. J. Control. Release. 38:1996;159-165.
-
(1996)
J. Control. Release
, vol.38
, pp. 159-165
-
-
Santi, P.1
Guy, R.H.2
|